ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TRX Tissue Regenix Group Plc

61.50
0.00 (0.00%)
16 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 61.50 61.00 62.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 24.48M -2.7M -0.0382 -16.10 43.4M
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 61.50p. Over the last year, Tissue Regenix shares have traded in a share price range of 49.00p to 71.50p.

Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £43.40 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -16.10.

Tissue Regenix Share Discussion Threads

Showing 9026 to 9049 of 14750 messages
Chat Pages: Latest  362  361  360  359  358  357  356  355  354  353  352  351  Older
DateSubjectAuthorDiscuss
09/5/2018
10:43
Tissue Regenix will be presenting to investors at the Proactive One2One Healthcare Forum taking place on the evening of 17th May in London. For details and registration, please click here:
aim_trader
19/4/2018
15:51
Well, Woodford has bought more; so at least there's one person, other than me, keeping the faith!
andrewbaker
04/4/2018
20:01
Is they the house broker. If so it don't mean jack
swiss paul
20/3/2018
10:24
Agree graham, and I am sitting with a few more than that in the hope of a good end value !!
channel pirate
20/3/2018
10:09
Possibly correct, CP, but in the larger scheme of shareholdings a near quarter of a million shares may be large in numbers, but is not that significant in terms of end value.
grahamburn
20/3/2018
09:42
Delayed SELL from yesterday of 241,159 @ 8.10p showing up today. Now is that someone who is desperate for "cash" or a bit of knowledge of what is coming in the Results next Monday ??
channel pirate
08/3/2018
10:08
New Hardman Report - posted on LSE by "sandhopper"

hxxp://hardmanandco.com/docs/default-source/company-docs/tissue-regenix--documents/08.03.18-full-year-2017-what-to-look-for.pdf

channel pirate
26/2/2018
07:43
My wife is a nurse and she has mentioned before how some wounds are hard to heal and can become long term problems. While not a clinician myself, I do wonder why Dermapure is not flying off the shelves. Having followed its development from the sidelines, it sounds like an exceptionally effective product - as confirmed today and one that is already changing surgeons behaviour. Is it too expensive?

I am waiting for the day this really starts to take off, as I am sure it will.

molatovkid
26/2/2018
07:17
2 X RNS's today !!

Let's hope we get some positive share price lifting results on 19th March then:


26/02/2018 7:01am

UK Regulatory (RNS & others)

Tissue Regenix (LSE:TRX)
Intraday Stock Chart

Today : Monday 26 February 2018
Click Here for more Tissue Regenix Charts.
TIDMTRX

RNS Number : 8568F

Tissue Regenix Group PLC

26 February 2018

Tissue Regenix Group plc

Notice of Results

Leeds, 26 February 2018 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company announces it will release its unaudited preliminary results for the year ended 31 December 2017 on Monday 19 March.

Further information regarding an analyst call will follow in due course.

For more Information:

Tissue Regenix Group plc Tel: 0330
Caitlin Pearson Head of Communications 430 3073
/ 07920272
441
---------------------------------------- ------------
Jefferies International Ltd Tel: 020
Simon Hardy / Christopher Binks 7029 8000
---------------------------------------- ------------
FTI Consulting Tel: 0203
Brett Pollard / Mo Noonan/ Rob Winder 727 1000

channel pirate
22/2/2018
21:11
Sound familiar?
From Mr C on Lemon fool:
Sinclair Pharma (SPH) drops US distributor for Silhouette InstaLift end March, by mutual agreement. "Sinclair will pay to Thermi a one-off, undisclosed payment for the early termination and will regain the full US distribution rights for the Products." Why the payment if the termination is mutual? "Advanced discussions with potential US partners are ongoing and we expect to enter into an alternative arrangement effective from 1 April".

SPH: Price=22. Cap=111m. F/C for current FY*: EPS= -1.31, Prospective PE= -16.8, Revenue=NA.
Sinclair Pharma is a specialty pharmaceutical company focused on Dermatology, in particular - Aesthetics, Wound care, and Skin care.

How is the U side of the business?

swiss paul
26/1/2018
08:37
Steve Couldwell [new CEO] and Neil Hunt [Knee surgeon] speak on first vid.

Innovations in soft tissue regenerative medical technology – Tissue Regenix




Healing skeletal defects through regenerative medicine – CellRight Technologies

bamboo2
03/1/2018
11:21
I kept the faith, and held on: hopefully the reward will come this year, as things do now seem to be stirring!
andrewbaker
21/12/2017
12:51
channel pirate, that was a much better response. Thank you for your thoughts.

I don't really like to read older posts, it can be far too time consuming. I will take a look at some of your previous posts though.

Once again thank you and good luck.

TMK

tees maar khan
17/12/2017
08:09
TMK, if you look back through the posts here you will see that some long term shareholders have sold up and decided to sit on the side-lines waiting for what they think is the right time to jump back in - obviously they may think now is not the right time to be invested here, but some time in the future as the company grows might be a better time.

Look at my post 2045 and you will see there is 84.83% of the company shares not in public hands right now, that might tell you something.

Me - I have a decent holding that I am happy to wait for hopefully a nice return, but that does no mean to say I am right - buying stock listed on the AIM is a gamble - some you win, some you loose.

Good Luck

channel pirate
16/12/2017
23:34
Channel Pirate, So you cannot say in a few words, what is the reason for this stock trading where it is?

I'll do my own research but was just trying to find out from existing shareholders?

You don't seem that sure or confident yourself about this company? If somebody asked me about a stock that I was invested in, I'd be happy to talk about it. Maybe I'm different.

TMK

tees maar khan
16/12/2017
22:26
TMK

Spend some time doing YOUR OWN research before you decide if to spend YOUR OWN money is the best advice - everytime.

Good Luck with whatever decision you make.

channel pirate
16/12/2017
20:22
Hi, could someone please tell me what the near term catalysts are for this company?

I have not had the time to research this at length yet. I would very much appreciate it if someone could run me up to speed.

In a nutshell what is the investment case here.

TMK

tees maar khan
14/12/2017
20:52
They did that when they brought on the big US sales force - anything happened since?
swiss paul
13/12/2017
22:29
Quite impressive line up...but who the heck is running the company. Surely they are not going to do the usual thing..and gift it too the Americans?!
rayrac
12/12/2017
06:43
Here are the stats ref share holding at 08th December 2017 as detailed on the company web page.

84.83% of the shares are NOT in public hands.

Here are TRG's biggest shareholding figures

Name of Shareholder: Invesco Limited % of Voting Rights: 28.99
Name of Shareholder: Woodford Investment Management LLP % of Voting Rights: 25.14
Name of Shareholder: Techtran Group Limited % of Voting Rights: 8.87
Name of Shareholder: Baillie Gifford & Co Ltd % of Voting Rights: 6.09
Name of Shareholder: Jupiter Asset Management % of Voting Rights: 5.93
Name of Shareholder: Directors & Related Holdings % of Voting Rights: 4.80
Name of Shareholder: IP2IPO Limited % of Voting Rights: 4.31

channel pirate
07/12/2017
15:34
they announced some time ago that they intend to have a capital day for analysts and invesrors and that has been delayed ; with tghe resgnation of ceo and cfo and no news the share price seems in free fall that can only leaves guessing to no bloody avail
ali47fish
07/12/2017
15:25
Well Ray...........From the RNS 20th July 2017...............
............Tissue Regenix also announces its intention to raise gross proceeds of approximately GBP40 million pursuant to a placing of up to 400 million new Ordinary Shares less the number of any Subscription Shares (as defined below) (the "Placing Shares") in the Company at a price of 10 pence per Placing Share, with both new and existing institutional investors (the "Placing").

Some big supporters of the company have seen their investment smashed since they added !!

channel pirate
07/12/2017
15:11
Can only be Woodford surely? There’s no one else left who could affect the share price this way.
rayrac
07/12/2017
14:43
someone must be adumping.
igbertsponk
Chat Pages: Latest  362  361  360  359  358  357  356  355  354  353  352  351  Older

Your Recent History

Delayed Upgrade Clock